Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein
- 1 November 2006
- journal article
- Published by Elsevier in Neuroscience
- Vol. 142 (4) , 1245-1253
- https://doi.org/10.1016/j.neuroscience.2006.07.005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Role of α-Synuclein in Presynaptic Dopamine RecruitmentJournal of Neuroscience, 2004
- Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-SynucleinJournal of Neuroscience, 2004
- Risk factors for dopaminergic neuron loss in human α‐synuclein transgenic miceEuropean Journal of Neuroscience, 2004
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic NeuronsJournal of Biological Chemistry, 2003
- Pathogenesis of parkinson's disease: dopamine, vesicles and α-synucleinNature Reviews Neuroscience, 2002
- Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promotersJournal of Neuroscience Research, 2002
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Effects ofl-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated ratsBrain Research, 1990